Cyclophosphamide is a widely used alkylating chemotherapeutic agent that interferes with DNA replication, leading to cell death, and is employed in the treatment of various cancers such as lymphoma, leukemia, and breast cancer, as well as in certain autoimmune disorders. It was first synthesized in 1958 by pharmaceutical researchers seeking nitrogen mustard derivatives with improved therapeutic profiles, and by the 1960s, it became a cornerstone in cancer chemotherapy due to its effectiveness and relative safety compared to earlier mustard-based drugs.